Encompass Health CORP Form 4 insider transactions

Director Edward M. Christie III increased his holdings in Encompass Health through dividend reinvestment and a deferred stock investment plan.

Elissa Charbonneau, Chief Medical Officer of Encompass Health Corp, reported a transaction involving the withholding of 2,991 shares of common stock to cover tax obligations.

Encompass Health's EVP and Chief Financial Officer, Douglas Coltharp, reported a transaction involving the withholding of 12,438 shares to cover tax obligations.

Encompass Health's EVP, General Counsel, and Secretary, John Patrick Darby, sold 5,917 shares of company stock to cover tax obligations related to vesting restricted stock.

Encompass Health CEO Mark Tarr sold 31,609 shares of company stock on January 1, 2025, to cover tax obligations related to vesting restricted stock.

Encompass Health's Senior Vice President and Treasurer, Edmund Fay, disposed of 2,291 shares of common stock to cover tax obligations related to vesting restricted stock.

Andrew L. Price, Chief Accounting Officer of Encompass Health Corp, sold 2,446 shares of company stock to cover tax obligations related to vesting restricted stock.

Encompass Health's EVP and Chief Financial Officer, Douglas E. Coltharp, gifted 65,229 shares of company stock to his spouse in a non-derivative transaction.

Terrance Williams, a director of Encompass Health Corp, acquired 24 shares of common stock through a dividend reinvestment program on October 15, 2024.

Director Christopher R. Reidy reports acquisitions of Encompass Health Corp stock through dividend reinvestment and participation in the Directors Deferred Stock Investment Plan.

Director Nancy M. Schlichting reports the acquisition of additional restricted stock units (RSUs) in Encompass Health Corp due to a dividend payment.

Director Kevin J. O'Connor reports the acquisition of 14 restricted stock units of Encompass Health Corp due to a dividend payment.

Director Patricia Anne Maryland acquired 24 restricted stock units of Encompass Health Corp due to a dividend payment on October 15, 2024.

Leslye G. Katz, a director of Encompass Health Corp, acquired 81 shares of common stock through a dividend reinvestment program on October 15, 2024.

Director Joan E. Herman reports acquiring 81 restricted stock units of Encompass Health Corp due to a dividend payment.

Director Edward M. Christie III reports acquisition of Encompass Health Corp shares through dividend reinvestment and deferred stock investment plan.

Director Greg D. Carmichael reports dividend reinvestments and restricted stock unit awards, increasing his holdings in Encompass Health common stock.

Encompass Health's EVP & CFO, Douglas Coltharp, exercised stock options and sold shares on August 13, 2024, according to a Form 4 filing with the SEC.

Terrance Williams, a director at Encompass Health Corp, acquired 24 shares of common stock due to a dividend reinvestment program.

Director Nancy M. Schlichting reports acquiring 35 shares of Encompass Health Corp through dividend reinvestment on July 15, 2024.

Christopher R. Reidy, a director at Encompass Health Corp, increased his holdings through dividend reinvestments and participation in the Directors Deferred Stock Investment Plan.

Director Kevin J. O'Connor acquired 13 shares of Encompass Health Corp through dividend reinvestment on July 15, 2024.

Patricia Anne Maryland, a director at Encompass Health Corp, acquired 24 restricted stock units (RSUs) due to a dividend payment on July 15, 2024.

Leslye G. Katz, a director of Encompass Health Corp, reported acquiring 80 shares of common stock due to a dividend reinvestment program.

Director Joan E. Herman reports the acquisition of 80 restricted stock units (RSUs) of Encompass Health Corp due to dividend payments.

Director Edward M. Christie III increases his holdings in Encompass Health through dividend reinvestment and participation in the Directors Deferred Stock Investment Plan.

Greg D. Carmichael, a director at Encompass Health Corp, acquired 24 shares of common stock due to a dividend reinvestment program.

Elissa Joy Charbonneau, Chief Medical Officer of Encompass Health Corp, sold 10,000 shares of common stock at an average price of $85.02 on May 24, 2024.

Encompass Health's EVP, General Counsel & Secretary, John Patrick Darby, exercised stock options and sold shares on May 6, 2024.

Director Greg D. Carmichael of Encompass Health Corp (EHC) recently acquired 2,000 shares of company stock at a price of $83.73 per share.